Stocks
Vertex’s Casgevy Approved for Children as Young as Two
Vertex Pharmaceuticals (VRTX) has received US FDA approval for its gene therapy Casgevy, expanding its indication to children as young as two...
Vertex Pharmaceuticals (VRTX) has received US FDA approval for its gene therapy Casgevy, expanding its indication to children as young as two...